This new initiative brings together provider groups, purchasers and end users committed to evidence-based, cost-effective, equitable digital health solutions.
In a time where the demand for digital health technologies is needed, the Digital Health Collaborative, a new organization dedicated to advancing the evidence and adoption of digital health solutions, has gained support from 14 leading healthcare and consumer organizations.
© stock.adobe.com
Despite advancements in this space, purchasers are challenged with determining the best solutions for their digital health needs.
This new initiative brings together provider groups, purchasers and end users committed to evidence-based, cost-effective, equitable digital health solutions.
The Peterson Health Technology Institute (PHTI), an initiative of the Peterson Center on Healthcare, is a supporter of the Collaborative.
PHTI assesses digital health solutions to determine their clinical effectiveness and financial impact for purchasers like payers, providers, and employers on behalf of patients.
Meg Baron, managing director of engagement and outreach at PHTI shared with Managed Healthcare Executive, "Collaborative members will jointly work together on research, programs, and knowledge sharing to help raise purchaser confidence and adoption of digital health solutions. Initial activities will include a national survey of digital health purchasers, grantmaking through a Research and Impact Fund, and regular convenings, including at an annual Summit."
Collaborative members include:
Through support from PHTI, the Collaborative will offer the Research and Impact Fund for aligned research and programs.
The first grant was awarded to DiMe for its Integrated Evidence Plans for Digital Health Products project to help developers align digital health products with purchaser evidence requirements.
“With a growing market of digital health solutions available to providers and consumers, the Digital Health Collaborative will play an important role in helping to bring together the perspectives and voices across the health system to meaningfully share insights on new and emerging technology,” Danielle Lloyd, senior vice president of Private Market Innovations and Quality at AHIP, said. “We hope the Collaborative’s research, analysis and data initiatives can help fill important gaps in assessing clinical value and health outcomes for stakeholders across the health system.”
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Conversations with Perry and Friends: Saar Mahna, J.D., MBA
July 7th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the "Conversations with Perry and Friends" podcast. In this episode, Cohen speaks with Saar Mahna, J.D., MBA, CEO and founder of Banjo Health, an artificial intelligence company focused on prior authorization.
Listen
PBM-Offered Genomics Testing Could Reshape Prescribing of Medications
July 25th 2025Two PBMs, True Rx Health Strategies and Capital Rx, are using pharmacogenomics — how a person’s DNA affects their response to medications — to reduce the trial-and-error of prescribing medications, saving employers and patients time and money.
Read More
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
FDA Accepts Tabelecleucel BLA; Priority Review Granted for Post-Transplant Disease Therapy
July 24th 2025The FDA has accepted the resubmitted BLA for tabelecleucel (tab-cel), intended for the treatment of Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD).
Read More